Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-003512
Filing Date
2025-08-12
Accepted
2025-08-12 09:06:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11629
2 JOINT ACQUISITION STATEMENT p25-1727exhibit991.htm EX-99.1 3760
  Complete submission text file 0000902664-25-003512.txt   17070
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 617-867-2800
Adage Capital Management, L.P. (Filed by) CIK: 0001535978 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Subject) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88701 | Film No.: 251204584
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)